OXFORD TEXTBOOK OF COGNITIVE NEUROLOGY AND DEMENTIA

• Section 1: Normal cognitive function
1: Charles Gross: Historical aspects of neurology
2: Giovanna Zamboni: Functional specialisation and network connectivity in brain function
3: Teresa Torralva, Ezequiel Gleichgerrcht, Agustin Ibañez, and Facundo Manes: The frontal lobes
4: Morgan D. Barense, Jason D. Warren, Timothy J. Bussey, and Lisa M. Saksida: The temporal lobes
5: Masud Husain: Parietal cortex
6: Geraint Rees: The human occipital lobe
7: James Rowe and Timothy Rittman: The basal ganglia in cognitive disorders
8: Marco Catani: Principles of white matter organization
9: Trevor W. Robbins: Neurochemistry of cognition
• Section 2: Cognitive dysfunction
10: Seyed A Sajjadi and Peter J. Nestor: Bedside assessment of cognition
11: Diana Caine and Sebastian Crutch: Neuropsychological assessment
12: Dalia Abou Zeky and Argye E. Hillis: Acquired disorders of language and speech
13: Lara Harris, Kate Humphreys, Ellen M. Migo, and Michael D. Kopelman: Memory disorders
14: Anna Katharina Schaadt and Georg Kerkhoff: Vision and visual processing deficits
15: Paolo Bartolomeo and Raffaella Migliaccio: Disorders of attentional processes
16: Georg Goldenberg: Apraxia
17: Marinella Cappelletti: The neuropsychology of acquired calculation disorders
18: Alexander P. Leff: Disorders of reading and writing
19: Dylan Wint and Jeffrey Cummings: Neuropsychiatric aspects of cognitive impairment
• Section 3: Cognitive impairment and dementia
20: Thais Minett and Carol Brayne: Epidemiology of dementias
21: Jonathan M. Schott, Nick C. Fox, and Martin N. Rossor: Assessment and investigation of the cognitively impaired adult
22: Barbara C. van Munster, Sophia de Rooij, and Sharon K. Inouye: Delirium, drugs, toxins
23: Sam Nightingale, Benedict Daniel Michael, and Tom Solomon: CNS infections
24: Nicholas J. C. Smith and Timothy M. Cox: Metabolic dementia
25: Geert Jan Biessels and Philip Scheltens: Vascular cognitive impairment
26: Sergi Martinez-Ramirez, Steven M. Greenberg, and Anand Viswanathan: Cerebral amyloid angiopathy and CNS vasculitis
27: Maria A. Ron: CNS inflammatory causes: Multiple sclerosis
28: Sarosh R. Irani, Thomas D. Miller, and Angela Vincent: CNS inflammatory causes: Autoimmune encephalitis
29: Tamas Revesz, Tammaryn Lashley, and Janice L. Holton: Pathology of degenerative dementias
30: Rita Guerreiro and Jose Bras: Genetics of degenerative dementias
31: Davina J. Hensman Moss, Nicholas W. Wood, and Sarah J. Tabrizi: Other genetic causes of cognitive impairment
32: Bruno Dubois and Olga Uspenskaya: Changing concepts and new definitions for Alzheimer's disease
33: Susan Rountree and Rachelle S. Doody: Presentation and Management of Alzheimer's disease
34: Jonathan D. Rohrer and Jason D. Warren: Primary progressive aphasia
35: Bruce Miller and Soo Jin Yoon: Frontotemporal dementia
36: Hasmet A. Hanagasi, Basar Bilgiç, and Murat Emre: Dementia with lewy bodies and Parkinson's disease dementia
37: Elizabeth A. Coon and Keith A. Josephs: Corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy, argyrophilic grain disease and rarer neurodegenerative diseases
38: Simon Mead, Peter Rudge, and John Collinge: Prion diseases
39: David J. Sharp, Simon Fleminger, and Jane Powell: Traumatic brain injury (TBI)
40: Tom Foltynie and Ludvic Zrinzo: Neurosurgery for cognitive disorders
41: Philip D. Harvey: Cognition in severe mental illness: Schizophrenia, bipolar disorder and depression

Part of the Oxford Textbooks in Clinical Neurology series, the Oxford Textbook of Cognitive Neurology and Dementia covers the dramatic developments that have occurred in the basic neuroscience and clinical research in both cognitive neurology and dementia in an integrated fashion. The text is firmly based on the clinical approach to the patient with cognitive impairment and dementia, while also providing the essential background scientific knowledge that is fundamental to clinical practice.
Divided into three main sections, this book combines the basic science (Section 1) with different types of cognitive deficit or neuropsychological presentation (Section 2), and disease specific chapters (Section 3).
With contributions from a range of international experts, this is essential reading for clinicians with an interest in cognition and dementia including neurologists, geriatricians and psychiatrists. It provides a powerful means of bringing together different aspects of conceptual understanding and factual knowledge, in a way that usually can only come after many years in the field.

Features
• An accessible, authoritative book aimed at the clinician, which spans basic neuroscience and clinical research areas in an integrated fashion.
• The one essential textbook for clinicians with an interest in cognition and dementia, for neurologists, geriatricians and psychiatrists who are involved in assessing and treating these patients.
• A textbook that is more than the sum of its constituent parts, providing a powerful means of bringing together different aspects of conceptual understanding and factual knowledge in a way that usually can only come after many years in the field.

Authors
• Masud Husain, Professor of Neurology & Cognitive Neuroscience, Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, UK.
Masud Husain is Professor of Neurology & Cognitive Neuroscience at the Nuffield Department of Clinical Neurosciences, University of Oxford, UK. He is an experienced clinician who leads a research team focused on cognitive disorders in neurological diseases. His work is supported by a Principal Research Fellowship from the Wellcome Trust. Wellcome Trust.
• Jonathan M. Schott, Reader in Clinical Neurology, Dementia Research Centre, Department of Neurodegenerative Diseases, UCL Institute of Neurology, UK.
onathan M. Schott is Reader in Clinical Neurology and Honorary Consultant Neurologist at the Dementia Research Centre, UCL Institute of Neurology. An experienced cognitive neurologist running a busy cognitive disorders clinic, he has an extensive portfolio of translational clinical research in dementias, with particular interests in how clinical assessment, biomarkers and genetics can be combined to improve diagnosis and identify pre-symptomatic Alzheimer's disease. Both editors serve on a number of national and international bodies influencing clinical practice and research, and are committed to translating research advances into improved patient care. In this textbook, they have brought together an expert, international team to provide a practical resource for busy clinicians.